Page 1 of Clinical Trials for oxaliplatin, 948 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Last Updated: June 22, 2010
Condition(s): Colorectal Cancer
2
Recruiting
Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
Last Updated: December 23, 2011
Condition(s): Carcinoma
3
Recruiting
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Last Updated: October 4, 2011
Condition(s): Colorectal Neoplasm
4
Completed
Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
Last Updated: September 25, 2009
Condition(s): Gastric Cancer
5
Not yet recruiting
Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection
Last Updated: February 15, 2012
Condition(s): Advanced Gastric Carcinoma
6
Completed
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
Last Updated: December 29, 2011
Condition(s): Hepatoma; Advanced Solid Tumor
7
Completed
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL
Last Updated: October 25, 2011
Condition(s): Leukemia
8
Recruiting
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Last Updated: January 12, 2010
Condition(s): Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer
9
Completed
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
Last Updated: March 5, 2012
Condition(s): Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
10
Recruiting
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
Last Updated: March 2, 2012
Condition(s): Gastric Cancer
11
Recruiting
Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
Last Updated: April 17, 2012
Condition(s): Carcinoma of the Appendix; Primary Peritoneal Cavity Cancer
12
Completed
Isolated Liver Perfusion With Oxaliplatin
Last Updated: December 8, 2011
Condition(s): Unresectable Colorectal Liver Metastases
13
Recruiting
Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma
Last Updated: February 3, 2012
Condition(s): Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer
14
Completed
Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer
Last Updated: April 8, 2010
Condition(s): Colorectal Cancer
15
Completed
Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
Last Updated: December 29, 2011
Condition(s): Advanced Solid Tumors
16
Withdrawn
A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin
Last Updated: October 18, 2011
Condition(s): Colorectal Carcinoma; Neoplasms, Colorectal; Colorectal Cancer; Colorectal Tumors; Metastasis
17
Completed
Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
Last Updated: March 15, 2012
Condition(s): Metastatic Colorectal Cancer; Responsive to Fluoropyrimidines; Advanced Colorectal Cancer; Neoplasms, Colorectal
18
Active, not recruiting
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Last Updated: October 17, 2011
Condition(s): Anal Cancer
19
Completed
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer
Last Updated: December 21, 2011
Condition(s): Breast Cancer
20
Recruiting
Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
Last Updated: January 18, 2012
Condition(s): Phase I: To Determine the Maximum Tolerated Dose (MTD); Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/Oxaliplatin

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=oxaliplatin

Page 1 of Clinical Trials for oxaliplatin, 948 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About